News
3T Biosciences Builds Transatlantic Pan-Cancer Research Pipeline to Target Most Difficult-to-Treat Cancers
Boehringer Ingelheim and 3T Biosciences enter into a second partnership to develop next-generation cancer immunotherapies
Publications
- 3T Platform & TCR Profiling
- Target Identification for Autoimmune Disease
- Target Identification for Oncology Indications
Stress-testing the relationship between T cell receptor/peptide-MHC affinity and cross-reactivity using peptide velcro
Proceedings of the National Academy of Sciences (PNAS)
T cell receptor cross-reactivity expanded by dramatic peptide/MHC adaptability
Nature Chemical Biology
Intracellular targets as source for cleaner targets for the treatment of solid tumors
Biochemical Pharmacology